GUARDO, DANIELA
 Distribuzione geografica
Continente #
EU - Europa 518
Totale 518
Nazione #
IT - Italia 518
Totale 518
Città #
Genova 266
Genoa 129
Rapallo 99
Vado Ligure 20
Bordighera 4
Totale 518
Nome #
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 131
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 121
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia 115
Underlying CTLA4 deficiency in a patient with juvenile idiopathic arthritis and autoimmune lymphoproliferative syndrome features successfully treated with abatacept - A case report 50
The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders 46
Genetic screening of children with marrow failure. The role of primary Immunodeficiencies 29
Targeted ngs yields plentiful ultra-rare variants in inborn errors of immunity patients 22
Good tolerability of high dose colistin-based therapy in patients with haematological malignancies 21
Infection risk of Mycophenolate Mofetil and Sirolimus treatments in patients with Autoimmune Cytopenias and Primary Immuno-Regulatory Disorders. 10
Hematopoietic stem cell transplantation for inborn errors of immunity: 30-year single-center experience 5
Totale 550
Categoria #
all - tutte 2.663
article - articoli 2.614
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020100 0 0 4 12 11 15 14 10 12 12 8 2
2020/202140 2 3 2 1 6 3 0 7 3 4 2 7
2021/202279 1 1 6 7 2 6 2 10 11 16 3 14
2022/2023121 11 16 2 10 18 14 0 2 15 8 21 4
2023/2024113 0 10 2 12 9 11 6 20 7 4 20 12
2024/202524 7 14 3 0 0 0 0 0 0 0 0 0
Totale 550